Be part of the knowledge.

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Optimizing Outcomes in Diabetic Retinopathy: Improving Screening, Referral, and Treatment

The past 40 years have witnessed great advancements in therapeutic options for treating diabetic retinopathy. Despite a number of effective treatme...

Available credits: 0.50

Time to complete: 30 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    The past 40 years have witnessed great advancements in therapeutic options for treating diabetic retinopathy. Despite a number of effective treatment options, diabetic eye disease is one of the leading causes of vision loss in the United States, in part because many patients are not identified as needing therapy. In addition to counseling patients on the importance glucose control on maintaining vision, clinicians should emphasize the need for regular vision tests among patients with diabetes. Early detection offers the best long-term visual outcomes and is even more important with new treatments approved for the management of diabetic retinopathy. 

    As a value added-resource, a specialized toolkit will also be included as a supplement to the webcast. The toolkit will provide for clinicians clinical practice guidelines and recommendations for screening and diagnosis. In addition, the toolkit will provide helpful information and resources for patients, their families and caregivers.

  • Learning Objectives

    • Examine the pathophysiology behind diabetic retinopathy to better comprehend how treatment may improve vision loss
    • Recognize risk factors and employ current screening and referral guidelines to assist in the prevention of visual loss in patients with diabetes
    • Apply evidence-based medicine and best practices for the optimal use of intravitreal anti-VEGF therapy in the treatment of diabetic retinopathy
    • Incorporate effective communication techniques and educational tools to improve the patient's knowledge of diabetic retinopathy
  • Target Audience

    The intended audiences for this activity are physicians and other health care professionals who manage patients with diabetic retinopathy.

  • Disclosure of Conflicts of Interest

    Rishi P. Singh, MD 
    Staff Surgeon
    Cole Eye Institute
    Cleveland Clinic
    Associate Professor of Ophthalmology 
    Lerner College of Medicine 
    Medical Director of Informatics
    Cleveland Clinic 
    Cleveland, OH

    Matt Birnholz, MD
    Johns Hopkins School of Medicine
    Children's Memorial Hospital of Chicago
    Northwestern University Feinberg School of Medicine

    Disclosure of Conflicts of Interest:
    According to the disclosure policy of the University of Cincinnati College of Medicine, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with the commercial companies related to this activity.  All relevant relationships that are identified are reviewed for potential conflicts of interest. If a conflict of interest is identified, it is the responsibility of the University Of Cincinnati College Of Medicine to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

    The following faculty has reported real or apparent conflicts of interest that have been resolved:

    Rishi P. Singh, MD has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Alcon, Genentech, Optos, Optovue, Regeneron
    Received grants for clinical research from: Alcon, Apellis, Genentech

    Matt Birnholz, MD (host) has nothing to disclose.

    The following reviewers/planners/authors have reported real or apparent conflicts of interest:

    • Susan Tyler, MEd, CMP, CHCP, CME Director, has nothing to disclose.
    • Rick E. Ricer, MD, Professor Emeritus, CME Reviewer, has nothing to disclose.
    • Deborah Cole, BS, Program Coordinator, has nothing to disclose.
    • Otto Ratz, MD, has nothing to disclose.
    • Christina Culbert, MSc, has nothing to disclose.
  • Accreditation and Credit Designation Statements

    Accreditation Statement
    This CME activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and CORE Medical Education, LLC. University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

    Credit Designation
    University of Cincinnati designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    This CME activity was developed through the joint providership of the University of Cincinnati and CORE Medical Education, LLC.

  • Commercial Support

    This CME activity is supported by an educational grant from Genentech, Inc.

  • Terms of Use

    Disclosure of Unlabeled Use
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither the University of Cincinnati College of Medicine nor CORE Medical Education, LLC, recommends the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati College of Medicine or CORE Medical Education, LLC. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

  • Instructions

    There are no fees for participating in and receiving CME credit for this online activity. During the period of December 15, 2016 to December 31, 2017, participants must 1) read the CME information, including the learning objectives and faculty disclosures; 2) listen to the full content of the activity and reflect upon its teachings; 3) successfully complete the post-test with a passing score of 70% and the evaluation at the end of the activity.

    Participants who successfully complete the activity, post test and evaluation will have a statement of credit made available immediately.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of ReachMD. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ReachMD you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.